Literature DB >> 1476395

Markers of vascular injury in Behçet's disease associated with retinal vasculitis.

P Pivetti-Pezzi1, R Priori, G Catarinelli, P L Meroni, A B Federici, M Abdulaziz, M Falco, G Valesini.   

Abstract

The pathogenesis of vascular damage in Behçet's disease (BD) is still unknown. We investigated anticardiolipin antibodies (AC) in a genetically homogeneous group of Italian patients with BD and retinal vasculitis. In a subset, we examined the level of factor VIII-related antigen and antiendothelial cell antibodies (AECA). We found a high prevalence of AC; AECA were not found in most of our patients. Only three patients had raised levels of factor VIII-related antigen, all of whom had systemic involvement. We believe BD may be considered as a vasculitis of unknown origin in which several and different pathogenetic factors may play a role.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1476395

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  6 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

2.  Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study.

Authors:  C D Kalogeropoulos; P Spyrou; M I Stefaniotou; E E Tsironi; A A Drosos; K G Psilas
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

3.  Antiannexin V autoantibody in thrombophilic Behçet's disease.

Authors:  H Aslan; S Pay; F Gok; Y Baykal; M I Yilmaz; A Sengul; H I Aydin
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

4.  Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.

Authors:  R Cervera; M Navarro; A López-Soto; M C Cid; J Font; J Esparza; J C Reverter; J Monteagudo; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

5.  Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease.

Authors:  H Direskeneli; G Keser; D D'Cruz; M A Khamashta; T Akoğlu; H Yazici; S Yurdakul; V Hamuryudan; S Ozgün; A J Goral
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

Review 6.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.